PRELID1 Polyclonal antibody

PRELID1 Polyclonal Antibody for IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

IHC, ELISA and More (1)

Conjugate

Unconjugated

Cat No : 10877-1-AP

Print datasheet

Synonyms

CGI 106, PRELI, PRELI domain containing 1, PRELID1, PX19, Px19 like protein, SBBI12



经过测试的应用

Positive IHC detected inhuman breast cancer tissue, human colon cancer tissue, human liver cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

推荐稀释比

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

发表文章中的应用

WBSee 1 publications below

产品信息

10877-1-AP targets PRELID1 in WB, IHC, ELISA applications and shows reactivity with human samples.

Tested Applications IHC, ELISA
Cited ApplicationsWB
Tested Reactivity human
Cited Reactivityhuman
Immunogen PRELID1 fusion protein Ag1037 种属同源性预测
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Full Name PRELI domain containing 1
Synonyms CGI 106, PRELI, PRELI domain containing 1, PRELID1, PX19, Px19 like protein, SBBI12
Calculated Molecular Weight 25 kDa
GenBank Accession NumberBC008307
Gene Symbol PRELID1
Gene ID (NCBI) 27166
RRIDAB_2168787
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9Y255
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

实验方案

Product Specific Protocols
IHC protocol for PRELID1 antibody 10877-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
humanWB

Onco Targets Ther

Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma.

Authors - Dafeng Xu